1.
Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds – an optical coherence tomography substudy of the EVERBIO II trial. Swiss Med Wkly [Internet]. 2016 Jan. 3 [cited 2025 Oct. 29];146(0102):w14274. Available from:
https://smw.ch/index.php/smw/article/view/2139